Equity Research, Broker Reports, and media content on Mercia Technologies

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Mercia Technologies
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Mercia Technologies

Company Profile

  • Personnel
  • Mark Andrew Payton, CEO
  • Martin James Glanfield, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Mercia Technologies. We currently have 51 research reports from 7 professional analysts.

  • Open: 20.2p
  • Range Today: 19.7/21.0p
  • 52 Week: 13.8/38.5p
  • Daily Volume: 295.7k
  • Daily Liquidity: (0.07%)
  • # Shares: 440.1m
  • Market Cap: £90.2m
  • Latest PE (hist): 36.39
  • Div Yield:
Date Source Announcement
09Jul20 07:00 RNS Sale of The Native Antigen Company
01Jul20 07:00 RNS-R Portfolio company MIP Diagnostics raises £5.1m
11Jun20 07:00 RNS Notice of Results
27May20 11:08 RNS Mercia accredited by BBB under CBILS
14May20 07:00 RNS-R Medherant partners with Cycle Pharmaceuticals
06May20 07:00 RNS-R Investment into OXGENE
21Apr20 07:00 RNS-R British Business Bank increases Mercia’s mandate
  • Frequency of research reports


  • Research reports on

    Mercia Technologies

  • Providers covering

    Mercia Technologies